Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

Conclusion
Results can inform policymakers, healthcare providers and insurance companies about the costs and benefits associated with universal screening for LS and cascade genetic testing of relatives.

Source: Journal of Medical Genetics - August 19, 2022 Category: Genetics & Stem Cells Authors: Salikhanov, I., Heinimann, K., Chappuis, P., Buerki, N., Graffeo, R., Heinzelmann, V., Rabaglio, M., Taborelli, M., Wieser, S., Katapodi, M. C. Tags: Open access Screening Source Type: research